Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3961

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3961 9)

Packaging label for Atorvastatin Calcium 80 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a supply of 90 film-coated tablets. It includes prescription use instructions, manufacturer information from Apotex Research Pvt. Ltd., Bangalore, India, and various product identifiers such as NDC 68071-3961-9. The label also contains storage instructions and warnings to keep out of reach of children.*

FDA Label Image

Figure-01 (Figure 01)

A line graph showing cumulative incidence (%) over a period of 3.5 years comparing Atorvastatin and Placebo. The graph includes two lines: a solid line for Atorvastatin and a dashed line for Placebo, illustrating lower cumulative incidence with Atorvastatin. The chart also shows a hazard ratio (HR) value with confidence interval and p-value.*

FDA Label Image

Figure-02 (Figure 02)

A line graph comparing cumulative hazard percentages over time between placebo and Atorvastatin groups. The x-axis represents time to first primary endpoint through four years of follow-up in years, and the y-axis shows cumulative hazard percentage. The graph includes a hazard ratio (HR) of 0.63 with confidence intervals and a p-value of 0.001.*

FDA Label Image

Figure-03 (Figure 03)

A line graph comparing the percentage of subjects experiencing a cardiovascular event over five years between atorvastatin 10 mg and atorvastatin 80 mg groups. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio and p-value indicating statistical analysis of the comparison.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of atorvastatin calcium showing its molecular components, including the calcium ion associated with the atorvastatin molecule. The diagram depicts atomic connections and functional groups characteristic of atorvastatin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.